Want to join the conversation?
$DGX 2Q15 PR: Net revenues for the quarter were $1,925MM compared to $1,902MM in 2Q14, grew by 1.2% versus the prior year and grew 0.8% on an organic basis. Net income attributable to Quest Diagnostics was $118MM compared to $133MM in 2Q14. Adjusted net income for the quarter was $170MM compared to $157MM in 2Q14.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.